Dashboard
Once every cohort has had at least two years, the recent eras still do worse on both missing results and ghost protocols.
Recent eligible completion cohorts remain worse on both missing results and ghost protocols, while full visibility erodes.
Once every cohort has had at least two years, the recent eras still do worse on both missing results and ghost protocols.
Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.
Industry-focused missing-results stock, sponsor backlogs, and structural sparsity inside CT.gov.
Sponsor-class comparisons on rate, stock, and structural hiddenness rather than one flattened ranking.
Phase-by-phase disclosure gaps showing how silence changes along the development pathway.
Field-level missingness across publication links, IPD statements, descriptions, and locations.
Results-plus-publication visibility states showing how many older trials are fully visible, partly visible, or ghosted.
Keyword-classified therapeutic-area hiddenness mapping across common condition families.
Concentration and inequality analysis showing how much unresolved stock sits inside a thin sponsor slice.